General Services Administration Acquisition Regulation; Information Collection; Contract Financing Final Payment (GSA Form 1142 Release of Claims), 10684-10685 [2015-04116]
Download as PDF
10684
Federal Register / Vol. 80, No. 39 / Friday, February 27, 2015 / Notices
In this document, the
Commission released a public notice
announcing the meeting in accordance
with the Federal Advisory Committee
Act, this notice advises interested
persons that the Federal
Communications Commission’s (FCC)
Technological Advisory Council will
hold its first meeting of the
Technological Advisory Council for
2015.
Federal Communications Commission.
Julius P. Knapp,
Chief, Office of Engineering and Technology.
Wednesday, April 1, 2015, from
1:00 p.m. to 4:00 p.m.
ADDRESSES: Federal Communications
Commission, 445 12th Street SW.,
Washington, DC 20554.
FOR FURTHER INFORMATION CONTACT:
Walter Johnston, Chief, Electromagnetic
Compatibility Division, 202–418–0807;
Walter.Johnston@FCC.gov.
SUPPLEMENTARY INFORMATION: This is a
summary of the Commission’s Public
Notice, DA 15–184 released February
10, 2015, announcing the first meeting
of the Technological Advisory Council
for 2015. At its prior meeting on
December 4, 2014, the Council had
discussed possible work initiatives for
2015. These initiatives have been
discussed in the interim within the FCC,
with the TAC chairman, as well as with
individual TAC members. At the April
meeting, the FCC Technological
Advisory Council will discuss its
proposed work program for 2015. The
FCC will attempt to accommodate as
many people as possible. However,
admittance will be limited to seating
availability. Meetings are also broadcast
live with open captioning over the
Internet from the FCC Live Web page at
https://www.fcc.gov/live/. The public
may submit written comments before
the meeting to: Walter Johnston, the
FCC’s Designated Federal Officer for
Technological Advisory Council by
email: Walter.Johnston@fcc.gov or U.S.
Postal Service Mail (Walter Johnston,
Federal Communications Commission,
Room 7–A224, 445 12th Street SW.,
Washington, DC 20554). Open
captioning will be provided for this
event. Other reasonable
accommodations for people with
disabilities are available upon request.
Requests for such accommodations
should be submitted via email to
fcc504@fcc.gov or by calling the Office
of Engineering and Technology at 202–
418–2470 (voice), (202) 418–1944 (fax).
Such requests should include a detailed
description of the accommodation
needed. In addition, please include your
contact information. Please allow at
least five days advance notice; last
minute requests will be accepted, but
may be impossible to fill.
Notice to All Interested Parties of the
Termination of the Receivership of
10201, American National Bank,
Parma, Ohio
SUMMARY:
mstockstill on DSK4VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:05 Feb 26, 2015
Jkt 235001
[FR Doc. 2015–04202 Filed 2–26–15; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Notice is hereby given that the Federal
Deposit Insurance Corporation (‘‘FDIC’’)
as Receiver for American National Bank,
Parma, Ohio (‘‘the Receiver’’) intends to
terminate its receivership for said
institution. The FDIC was appointed
receiver of American National Bank on
March 19, 2010. The liquidation of the
receivership assets has been completed.
To the extent permitted by available
funds and in accordance with law, the
Receiver will be making a final dividend
payment to proven creditors.
Based upon the foregoing, the
Receiver has determined that the
continued existence of the receivership
will serve no useful purpose.
Consequently, notice is given that the
receivership shall be terminated, to be
effective no sooner than thirty days after
the date of this Notice. If any person
wishes to comment concerning the
termination of the receivership, such
comment must be made in writing and
sent within thirty days of the date of
this Notice to: Federal Deposit
Insurance Corporation, Division of
Resolutions and Receiverships,
Attention: Receivership Oversight
Department 34.1, 1601 Bryan Street,
Dallas, TX 75201.
No comments concerning the
termination of this receivership will be
considered which are not sent within
this time frame.
Dated: February 23, 2015.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2015–04043 Filed 2–26–15; 8:45 am]
BILLING CODE 6714–01–P
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–0080]; [Docket
2015–0001; Sequence 2]
General Services Administration
Acquisition Regulation; Information
Collection; Contract Financing Final
Payment (GSA Form 1142 Release of
Claims)
AGENCY:
Office of Acquisition Policy,
GSA.
Notice of request for comments
regarding an extension to an existing
OMB clearance.
ACTION:
Under the provisions of the
Paperwork Reduction Act, the
Regulatory Secretariat will be
submitting to the Office of Management
and Budget (OMB) a request to review
and approve an extension of a
previously approved information
collection requirement and the
reinstatement of GSA Form 1142,
Release of Claims, regarding final
payment under construction and
building services contract. GSA Form
1142 was inadvertently deleted as part
of the rewrite of GSAR regulations on
Contract Financing. GSA Contracting
Officers have used this form to achieve
uniformity and consistency in the
release of claims process.
DATES: Submit comments on or before:
April 28, 2015.
FOR FURTHER INFORMATION CONTACT: Ms.
Dana Munson, General Services
Acquisition Policy Division, GSA, (202)
357–9652 or email Dana.Munson@
gsa.gov.
SUMMARY:
Submit comments
identified by Information Collection
3090–0080, Contract Financing Final
Payment; (GSA Form 1142, Release of
Claims) by any of the following
methods:
• Regulations.gov: https://
www.regulations.gov. Submit comments
via the Federal eRulemaking portal by
searching the OMB Control number
3090–0080. Select the link ‘‘Comment
Now’’ that corresponds with
‘‘Information Collection 3090–0080,
Contract Financing Final Payment;
(GSA Form 1142, Release of Claims).’’
Follow the instructions on the screen.
Please include your name, company
name (if any), and ‘‘Information
Collection 3090–0080, Contract
Financing Final Payment; (GSA Form
1142, Release of Claims),’’ on your
attached document.
• Fax: 202–501–4067.
• Mail: General Services
Administration, Regulatory Secretariat
(MVCB), 1800 F Street NW.,
ADDRESSES:
E:\FR\FM\27FEN1.SGM
27FEN1
Federal Register / Vol. 80, No. 39 / Friday, February 27, 2015 / Notices
Washington, DC 20405. ATTN: Ms.
Hada Flowers/IC 3090–0080, Contract
Financing Final Payment; (GSA Form
1142, Release of Claims).
Instructions: Please submit comments
only and cite Information Collection
3090–0080, Contract Financing Final
Payment; (GSA Form 1142, Release of
Claims), in all correspondence related to
this collection. All comments received
will be posted without change to https://
www.regulations.gov, including any
personal and/or business confidential
information provided.
SUPPLEMENTARY INFORMATION:
A. Purpose
The General Services Administration
Acquisition Regulation (GSAR) clause
552.232–72 requires construction and
building services contractors to submit
a release of claims before final payment
is made to ensure contractors are paid
in accordance with their contract
requirements and for work performed.
GSA Form 1142, Release of Claims is
used to achieve uniformity and
consistency in the release of claims
process.
B. Annual Reporting Burden
Respondents: 2000.
Responses per Respondent: 1.
Hours per Response: .10.
Total Burden Hours: 200.
mstockstill on DSK4VPTVN1PROD with NOTICES
C. Public Comment
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat (MVCB), 1800 F
Street NW., Washington, DC 20405,
telephone (202) 501–4755. Please cite
OMB Control No. 3090–0080, Contract
Financing Final Payment; (GSA Form
1142, Release of Claims), in all
correspondence.
Dated: February 24, 2015.
Jeffrey A. Koses,
Director, Office of Acquisition Policy, Office
of Government-wide Policy.
[FR Doc. 2015–04116 Filed 2–26–15; 8:45 am]
BILLING CODE 6820–61–P
VerDate Sep<11>2014
18:05 Feb 26, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Determination and Declaration
Regarding Emergency Use of New In
Vitro Diagnostics for Detection of
Enterovirus D68
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
The Secretary of Health and
Human Services (HHS) is issuing this
notice pursuant to section 564 of the
Federal Food, Drug, and Cosmetic
(FD&C) Act, 21 U.S.C. 360bbb–3. On
February 6, 2015, the Secretary
determined that there is a significant
potential for a public health emergency
that has a significant potential to affect
national security or the health and
security of United States citizens living
abroad and that involves enterovirus
D68 (EV–D68). On the basis of this
determination, she also declared that
circumstances exist justifying the
authorization of emergency use of new
in vitro diagnostics for detection of
EV–D68 pursuant to section 564 of the
FD&C Act, subject to the terms of any
authorization issued under that section.
DATES: The determination and
declaration are effective February 6,
2015.
FOR FURTHER INFORMATION CONTACT:
Karen Mason, Centers for Disease
Control and Prevention, 1600 Clifton
Road MS–A34, Atlanta, GA 30333,
Telephone (404) 639–1297 (this is not a
toll free number).
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under Section 564 of the FD&C Act,
the Commissioner of the Food and Drug
Administration (FDA), acting under
delegated authority from the Secretary
of HHS, may issue an Emergency Use
Authorization (EUA) authorizing (1) the
emergency use of an unapproved drug,
an unapproved or uncleared device, or
an unlicensed biological product; or (2)
an unapproved use of an approved drug,
approved or cleared device, or licensed
biological product. Before an EUA may
be issued, the Secretary of HHS must
declare that circumstances exist
justifying the authorization based on
one of four determinations: (1) A
determination by the Secretary of
Homeland Security that there is a
domestic emergency, or a significant
potential for a domestic emergency,
involving a heightened risk of attack
with a chemical, biological, radiological,
or nuclear (‘‘CBRN’’) agent or agents; (2)
the identification of a material threat by
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
10685
the Secretary of Homeland Security
pursuant to section 319F–2 of the Public
Health Service (PHS) Act 1 sufficient to
affect national security or the health and
security of United States citizens living
abroad; (3) a determination by the
Secretary of Defense that there is a
military emergency, or a significant
potential for a military emergency,
involving a heightened risk to United
States military forces of attack with a
CBRN agent or agents; or (4) a
determination by the Secretary that
there is a public health emergency, or a
significant potential for a public health
emergency, that affects, or has a
significant potential to affect national
security or the health and security of
United States citizens living abroad, and
that involves a CBRN agent or agents, or
a disease or condition that may be
attributable to such agent or agents.2
Based on any of these four
determinations, the Secretary of HHS
may then declare that circumstances
exist that justify the EUA, at which
point the FDA Commissioner may issue
an EUA if the criteria for issuance of an
authorization under section 564 of the
FD&C Act are met. The Centers for
Disease Control and Prevention (CDC),
HHS, requested that the FDA, HHS,
issue an EUA for new in vitro
diagnostics for detection of EV–D68 to
allow the Department to take
preparedness measures based on
information currently available about
the EV–D68.
The determination of a significant
potential for a public health emergency,
and the declaration that circumstances
exist justifying emergency use of new in
vitro diagnostics for detection of
EV–D68 by the Secretary of HHS, as
described below, enable the FDA
Commissioner to issue an EUA for in
vitro diagnostics for detection of
EV–D68 for emergency use under
section 564 of the FD&C Act.
II. Determination by the Secretary of
Health and Human Services
On February 6, 2015, pursuant to
section 564 of the FD&C Act, I
determined that there is a significant
potential for a public health emergency
that has a significant potential to affect
national security or the health and
1 42
U.S.C. 247d–6b
amended by the Pandemic and All-Hazards
Preparedness Reauthorization Act, Public Law 113–
5, the Secretary may make determination of a public
health emergency, or a significant potential for a
public health emergency, under section 564 of the
FD&C Act. The Secretary is no longer required to
make a determination of a public health emergency
in accordance with section 319 of the PHS Act, 42
U.S.C. 247d, to support a determination or
declaration made under section 564 of the FD&C
Act.
2 As
E:\FR\FM\27FEN1.SGM
27FEN1
Agencies
[Federal Register Volume 80, Number 39 (Friday, February 27, 2015)]
[Notices]
[Pages 10684-10685]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04116]
=======================================================================
-----------------------------------------------------------------------
GENERAL SERVICES ADMINISTRATION
[OMB Control No. 3090-0080]; [Docket 2015-0001; Sequence 2]
General Services Administration Acquisition Regulation;
Information Collection; Contract Financing Final Payment (GSA Form 1142
Release of Claims)
AGENCY: Office of Acquisition Policy, GSA.
ACTION: Notice of request for comments regarding an extension to an
existing OMB clearance.
-----------------------------------------------------------------------
SUMMARY: Under the provisions of the Paperwork Reduction Act, the
Regulatory Secretariat will be submitting to the Office of Management
and Budget (OMB) a request to review and approve an extension of a
previously approved information collection requirement and the
reinstatement of GSA Form 1142, Release of Claims, regarding final
payment under construction and building services contract. GSA Form
1142 was inadvertently deleted as part of the rewrite of GSAR
regulations on Contract Financing. GSA Contracting Officers have used
this form to achieve uniformity and consistency in the release of
claims process.
DATES: Submit comments on or before: April 28, 2015.
FOR FURTHER INFORMATION CONTACT: Ms. Dana Munson, General Services
Acquisition Policy Division, GSA, (202) 357-9652 or email
Dana.Munson@gsa.gov.
ADDRESSES: Submit comments identified by Information Collection 3090-
0080, Contract Financing Final Payment; (GSA Form 1142, Release of
Claims) by any of the following methods:
Regulations.gov: https://www.regulations.gov. Submit
comments via the Federal eRulemaking portal by searching the OMB
Control number 3090-0080. Select the link ``Comment Now'' that
corresponds with ``Information Collection 3090-0080, Contract Financing
Final Payment; (GSA Form 1142, Release of Claims).'' Follow the
instructions on the screen. Please include your name, company name (if
any), and ``Information Collection 3090-0080, Contract Financing Final
Payment; (GSA Form 1142, Release of Claims),'' on your attached
document.
Fax: 202-501-4067.
Mail: General Services Administration, Regulatory
Secretariat (MVCB), 1800 F Street NW.,
[[Page 10685]]
Washington, DC 20405. ATTN: Ms. Hada Flowers/IC 3090-0080, Contract
Financing Final Payment; (GSA Form 1142, Release of Claims).
Instructions: Please submit comments only and cite Information
Collection 3090-0080, Contract Financing Final Payment; (GSA Form 1142,
Release of Claims), in all correspondence related to this collection.
All comments received will be posted without change to https://www.regulations.gov, including any personal and/or business
confidential information provided.
SUPPLEMENTARY INFORMATION:
A. Purpose
The General Services Administration Acquisition Regulation (GSAR)
clause 552.232-72 requires construction and building services
contractors to submit a release of claims before final payment is made
to ensure contractors are paid in accordance with their contract
requirements and for work performed. GSA Form 1142, Release of Claims
is used to achieve uniformity and consistency in the release of claims
process.
B. Annual Reporting Burden
Respondents: 2000.
Responses per Respondent: 1.
Hours per Response: .10.
Total Burden Hours: 200.
C. Public Comment
Public comments are particularly invited on: Whether this
collection of information is necessary and whether it will have
practical utility; whether our estimate of the public burden of this
collection of information is accurate, and based on valid assumptions
and methodology; ways to enhance the quality, utility, and clarity of
the information to be collected.
Obtaining Copies of Proposals: Requesters may obtain a copy of the
information collection documents from the General Services
Administration, Regulatory Secretariat (MVCB), 1800 F Street NW.,
Washington, DC 20405, telephone (202) 501-4755. Please cite OMB Control
No. 3090-0080, Contract Financing Final Payment; (GSA Form 1142,
Release of Claims), in all correspondence.
Dated: February 24, 2015.
Jeffrey A. Koses,
Director, Office of Acquisition Policy, Office of Government-wide
Policy.
[FR Doc. 2015-04116 Filed 2-26-15; 8:45 am]
BILLING CODE 6820-61-P